KCNK4
protein-codingpotassium two pore domain channel subfamily K member 4, the group of Potassium two pore domain channel subfamily K
Gene summary
This gene encodes a member of the TWIK-related arachidonic acid-stimulated two pore potassium channel subfamily. The encoded protein homodimerizes and functions as an outwardly rectifying channel. This channel is regulated by polyunsaturated fatty acids, temperature and mechanical deformation of the lipid membrane. This protein is expressed primarily in neural tissues and may be involved in regulating the noxious input threshold in dorsal root ganglia neurons. Alternate splicing results in multiple transcript variants. Naturally occurring read-through transcripts also exist between this gene and the downstream testis expressed 40 (TEX40) gene, as represented in GeneID: 106780802. [provided by RefSeq, Nov 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032714
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032714
Submitter: ClinGen
The *KCNK4* gene is located on chromosome 11 at 11q13.1 and encodes the potassium channel subfamily K, member 4, a 2-pore domain potassium ion channel that is expressed almost exclusively in the nervous system, and controls the resting membrane potential. *KCNK4* was first reported in relation to autosomal dominant facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth (FHEIG) syndrome in 2018 (Bauer et al., PMID: 30290154). FHEIG syndrome is a rare, multiple congenital anomalies syndrome characterized by variable intellectual disability and/or developmental delay, epilepsy, generalized hypertrichosis, and severe gingival overgrowth. Seven unique missense variants have been reported in 12 probands in 6 publications and in ClinVar (PMIDs: 30290154, 32981868, 37931962, 36683851, 37750049, 39146707. ClinVar: SCV002157627.3, SCV002761982.1) and are included in this curation. The mechanism of pathogenicity at this time is unknown. This gene-disease relationship is also supported by expression in relevant tissues and by biochemical function studies (PMIDs: 32913098, 36225112). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date September 4th, 2024 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0032714
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0032714
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0032714
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Dental; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KCNK4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_033310.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 123 | 3 | 129 | ||
| missense | 1 | 8 | 188 | 73 | 8 | 278 |
| nonsense | 8 | 2 | 10 | |||
| start loss | 0 | |||||
| frameshift | 13 | 2 | 15 | |||
| splice donor/acceptor (+/-2bp) | 3 | 1 | 4 | |||
| Total | 1 | 8 | 215 | 201 | 11 | 436 |
Highest pathogenic variant AF is 6.840769e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_201567.1 | 6 | MANE Select | |
| Ensembl | ENSP00000402797.2 | 6 | MANE Select | |
| RefSeq | NP_001304019.1 | 6 | Standard | |
| Ensembl | ENSP00000378033.2 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuronal System
- Phase 4 - resting membrane potential
- Cardiac conduction
- Muscle contraction
- TWIK related potassium channel (TREK)
Biological Process
- potassium ion transport
- memory
- sensory perception of pain
- stabilization of membrane potential
- regulation of ion transmembrane transport
Molecular Function
- voltage-gated ion channel activity
- potassium channel activity
- potassium ion leak channel activity
- temperature-gated cation channel activity
- mechanosensitived potassium channel activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- potassium channel complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000539216
- Coding exons
- 6
- Length
- 8730
- Individuals with no LoFs
- 125718
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125745
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.754 | 197 | 229 | 0.860 | 0.0000121 | 2440 |
| Missense (PolyPhen) | 76 | 90.557 | 0.83925 | 940 | ||
| Synonymous | -0.807 | 119 | 108 | 1.10 | 0.00000577 | 900 |
| Loss of Function | 2.03 | 6 | 14.3 | 0.421 | 7.18e-7 | 151 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Voltage-insensitive potassium channel (PubMed:22282805). Channel opening is triggered by mechanical forces that deform the membrane (PubMed:22282805, PubMed:25471887, PubMed:25500157). Channel opening is triggered by raising the intracellular pH to basic levels (By similarity). The channel is inactive at 24 degrees Celsius (in vitro); raising the temperature to 37 degrees Celsius increases the frequency of channel opening, with a further increase in channel activity when the temperature is raised to 42 degrees Celsius (By similarity). Plays a role in the perception of pain caused by heat (By similarity). Plays a role in the sensory perception of pain caused by pressure (By similarity). {ECO:0000250|UniProtKB:G3V8V5, ECO:0000250|UniProtKB:O88454, ECO:0000269|PubMed:22282805, ECO:0000269|PubMed:25471887, ECO:0000269|PubMed:25500157}.;
Intolerance Scores
- LoFtool
- 0.644
- RVIS EVS
- -0.2
- RVIS percentile EVS
- 38.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.655
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |